Robert Haddad
@DrHaddadRobertDivision Chief, Head and Neck Oncology. Dana Farber Cancer Institute. McGraw Chair in Head and Neck Oncology Professor of Medicine. Harvard Medical School
Similar User
@RobertFerrisMD
@DrEzraCohen
@DrUppaluri
@AHNSinfo
@HeadNeckMD
@imrtlee
@DrNabilSaba
@H_N_C_I_G
@RajasekaranMD
@duvvuri_md
@DrNeilGross
@DrJohndeAlmeida
@jdschoenfeld1
@jpzevallos
@BasuLab1
Doug is celebrating six years cancer-free this month! “When you have cancer, you say yes to things. You live life," he says. Your donation will help more patients like Doug become cancer-free. Let’s strike out cancer: jimmyfund.gives/KCANCER #KCANCER
Did you know @DrHaddadRobert and @DrChoueiri had a competitive streak? - @DanaFarber @RobGronkowski #Cancer #CancerResearch #DanaFarberCancerInstitute #YouthFoundation #Clinic #NationalCancerInstitute #OncoDaily #Oncology oncodaily.com/49490.html
Thank you @RobGronkowski & @Edelman11 for a wonderful #pickleball game to benefit @DanaFarber @TheJimmyFund —we are in this together to beat Cancer ! @DanaFarber @DrHaddadRobert @DanaFarber_GU @DanaFarberNews @PanMass @goldietaylor
We are getting ready @RobGronkowski and @Edelman11 !!! We hope you are practicing too ! Let us cure Cancer together ! #pickelball @DanaFarber @DanaFarber_GU @DrHaddadRobert @TheJimmyFund @goldietaylor @Patriots @DanaFarberNews charity.pledgeit.org/f/ozX6IMVf7v
I’m teaming up with @DrHaddadRobert to play pickeball against @RobGronkowski and raise funds for cancer research for @DanaFarber ! Help us beat the Gronk (and Cancer!) charity.pledgeit.org/f/ozX6IMVf7v
I’m teaming up with @DrHaddadRobert to play pickeball against @RobGronkowski and raise funds for cancer research for @DanaFarber ! Help us beat the Gronk (and Cancer!) charity.pledgeit.org/f/ozX6IMVf7v
Out today--DC dysfunction in HNSCC antiPD1 resistance w/ a mechanistic role for CCL5 in enhancing DC function/ T cell priming. Congrats to Shin/Michi! @BrighamSurgery @DanaFarberNews @DrHaddadRobert @HeadNeckMD @jdschoenfeld1 tinyurl.com/686af9e9
First targeted therapy found safe and shows anti-tumor activity in patients with rare head and neck cancer. @DanaFarber's Robert Haddad, MD (@DrHaddadRobert) details the findings that were presented at #ESMO23.
.@sueyom, @DrHaddadRobert, Nicole C. Schmitt, Angela L. Ferguson, and Barbara A. Burtness discussed "Clinical Trials" in a plenary session today at the AACR-AHNS Head and Neck Cancer Conference. #aacrAHNS23
This review discusses cisplatin ineligibility in pts with locally advanced #HNC #hncsm, summarizes the limited clinical evidence for adjuvant tx, & highlights ongoing clinical trials that have the potential to provide new tx options. sciencedirect.com/science/articl…
1/ Results from #COSMIC-313 are out @NEJM: 1st triplet combo (cabo/nivo/ipi) in #mRCC vs. a modern control (nivo/ipi). Initially presented as Plenary #ESMO22 session chaired by @CharlesSwanton @AndresC27622123 #ESMO22 Thread 🧵==> nejm.org/doi/full/10.10…
TRIO Panel - Immunotherapy in H&N Cancer: What We Know, What We Think We Know and What We Really Don't. Join us tomorrow in Boston with the great @KaramLab @lucmorrisnyc and @MaieStJohn @__COSM @Triological . l.core-apps.com/cosm2023/event…
Finally out, our analysis from CONDOR/HAWK/EAGLE Tumor Mutational Burden as a Predictor of Survival With D+T in Recurrent Head and Neck Squamous Cell Carcinoma , also reporting on bTMB @RobertFerrisMD @AstraZenecaUS @DrEzraCohen @AACR @DrUppaluri aacrjournals.org/clincancerres/…
Our paper on CT performance with ENE shows poor reproducibility among expert head/neck neuroradiologists and poor predictive value for histologic ENE rdcu.be/c42sc. @BenjaminKannMD @sueyom @DanaFarberNews @BWHRadEdu @BrighamWomens @DrVijayPatil11
Key question for trials is whether folks are comfortable randomizing to RT alone. The vote by @DrHaddadRobert suggests only a quarter of us are willing but hopefully@more in the context of a trial for a cleaner answer
Great question! Need voting options for weekly cisplatin and also why pt is cisplatin ineligible (some criteria are softer than others), but we need trials adding novel agents to RT and the highest vote count comes without level I data.
Pembrolizumab versus Cetuximab concurrent with radiotherapy in patient... sciencedirect.com/science/articl… No difference in outcomes.We still need to define SOC for cis ineligible pts . what is yours ? @DrNabilSaba @DavidSherMD @RobertFerrisMD @seanmmcbride
Out today Biomarkers predictive of response to pembrolizumab in head and neck cancer onlinelibrary.wiley.com/doi/10.1002/ca… we assess combined biomarker analysis from K012 and 055 @DrUppaluri @DrNabilSaba @KaramLab @DrEzraCohen
United States Trends
- 1. Mike 1,79 Mn posts
- 2. Serrano 242 B posts
- 3. Canelo 16,9 B posts
- 4. #NetflixFight 74 B posts
- 5. #arcane2spoilers N/A
- 6. Father Time 10,6 B posts
- 7. Logan 78,8 B posts
- 8. VANDER 5.303 posts
- 9. #netflixcrash 16,4 B posts
- 10. He's 58 27,7 B posts
- 11. Rosie Perez 15,1 B posts
- 12. Boxing 305 B posts
- 13. ROBBED 101 B posts
- 14. Shaq 16,4 B posts
- 15. #buffering 11,1 B posts
- 16. My Netflix 83,8 B posts
- 17. Tori Kelly 5.358 posts
- 18. Roy Jones 7.251 posts
- 19. Ramos 69,3 B posts
- 20. Muhammad Ali 19,5 B posts
Who to follow
-
Robert Ferris, MD, PhD
@RobertFerrisMD -
Ezra Cohen
@DrEzraCohen -
Ravi Uppaluri, MDPhD
@DrUppaluri -
AHNS
@AHNSinfo -
Glenn J. Hanna, M.D.
@HeadNeckMD -
Nancy Lee
@imrtlee -
Nabil Saba, MD
@DrNabilSaba -
Head and Neck Cancer International Group
@H_N_C_I_G -
Karthik Rajasekaran
@RajasekaranMD -
Umamaheswar Duvvuri MD PhD
@duvvuri_md -
Neil D. Gross, MD, FACS
@DrNeilGross -
John De Almeida
@DrJohndeAlmeida -
Jonathan Schoenfeld
@jdschoenfeld1 -
José P. Zevallos, MD, MPH, FACS
@jpzevallos -
Devraj Basu, MD, PhD, FACS
@BasuLab1
Something went wrong.
Something went wrong.